Twist Bioscience (TWST) Revenue (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Revenue data on file, last reported at $110.7 million in Q1 2026.

• Revenue for Q1 2026 came in at $110.7 million, up 19.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $409.5 million (up 17.77% YoY), and the FY2025 annual result was $376.6 million, up 20.32% from the prior year.
• Revenue climbed to $110.7 million in Q1 2026 per TWST's latest filing, from $103.7 million in the prior quarter.
• Over five years, Revenue peaked at $110.7 million in Q1 2026 and troughed at $48.1 million in Q1 2022.
• A 5-year average of $77.1 million and a median of $75.3 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue soared 60.24% in 2022, then advanced 13.59% in 2023.
• A 5-year view of Revenue shows it stood at $54.2 million in 2022, then surged by 31.81% to $71.5 million in 2023, then climbed by 24.08% to $88.7 million in 2024, then increased by 16.89% to $103.7 million in 2025, then gained by 6.77% to $110.7 million in 2026.
• Business Quant data shows TWST's Revenue at $110.7 million in Q1 2026, $103.7 million in Q4 2025, and $99.0 million in Q3 2025.